Vol. 1 Ventures

Vol. 1 Ventures is a venture capital fund investing in highly regulated sectors.

Based in CA

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $0 in lobbying spend across 9 quarterly filings, Vol. 1 Ventures is an active lobbying client. Their lobbying covers 25 issue areas. Active from 2023 to 2024.

$0
Total Spend
2
Years Active
1
Firms Hired
1
Lobbyists Deployed
25
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2023$0
2024$0

Issues Lobbied

AgricultureTaxationBankingFinancialScience/TechnologyFamily IssuesMEDBeverageLabor IssuesAccountingComputer IndustryAerospaceCopyright/PatentFood IndustryBudget/AppropriationsMedicare/MedicaidTransportationSmall BusinessConsumer IssuesAviationHealth IssuesInsurancePharmacyReal EstateAdvertising

Lobbying Firms

Vol. 1 Ventures

Lobbyists

Stevie Cline

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Agriculture, Taxation, Banking, Financial, Science/Technology and 20 more

Women's Health, Biotech, Diagnotics, Genetics, Tech Industry, Startups, Venture Capital, Fintech, PropTech, AgTech, Entrepreneurship Funding, Cryptocurrency, Blockchain Technologies, Web3, and Moonsho

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?
🏭 Tech Lobbying
Industry overview and top spenders
🏭 Pharma Lobbying
Industry overview and top spenders

Related Investigations

The 22,000% ROI
When lobbying spending yields outsized returns.
Follow the Money
Tracking lobbying dollars through the financial system.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
The Crypto Lobbying Explosion
How crypto went from zero to massive lobbying presence.
Who's Lobbying to Shape AI Policy
The AI regulation fight is the biggest lobbying battle of the decade.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.

Similar Clients

Jazz Pharmaceuticals, INC.
$11.5M total spend
Sarepta Therapeutics, INC.
$6.3M total spend
Greenwich Biosciences, INC.
$4.5M total spend
Vsp
$3.4M total spend
Hims & Hers Health, INC.
$2.3M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.